PCSK9 inhibitor added to high-intensity statin therapy to prevent cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention: a randomized, double- blind, placebo-controlled, multicenter SHAWN study-Reference-Cited by-同舟云学术

PCSK9 inhibitor added to high-intensity statin therapy to prevent cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention: a randomized, double- blind, placebo-controlled, multicenter SHAWN study

Published:2024-11 Issue: Volume:277 Page:58-65
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Wu Zhi-Ming^ORCID,Kan Jing,Ye Fei,You Wei,Wu Xiang-Qi,Tian Nai-Liang,Lin Song,Ge Zhen,Liu Zhi-Zhong,Li Xiao-Bo,Gao Xiao-Fei,Chen Jing,Wang Yan,Wen Shang-Yu,Xie Ping,Cong Hong-Liang,Liu Li-Jun,Zeng He-Song,Zhou Lei,Liu Fan,Zheng Yong-Hong,Li Rui,Ji Hong-Lei,Zhou Sheng-Hua,Zhao Shou-Ming,Qian Xue-Song,Luo Jun,Wang Xin,Zhang Jun-Jie,Chen Shao-Liang

Publisher

Elsevier BV

Reference34 articles.

1. Proprotein convertase subtilisin/kexin type 9 inhibition in cardiovascular disease: current status and future perspectives;Cho;Korean J Intern Med,2020

2. Detection by near-infrared spectroscopy of large lipid core plaques at culprit sites in patients with acute ST-segment elevation myocardial infarction;Madder;JACC Cardiovasc Interv,2013

3. Differential healing response attributed to culprit lesions of patients with acute coronary syndromes and stable coronary artery after implantation of drug-eluting stents: an optical coherence tomography study;Räber;J Cardiol,2014

4. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur Heart J,2020

5. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/ AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines;Grundy;Circulation,2019